278 related articles for article (PubMed ID: 26872386)
1. Prefrontal Lobe Brain Reserve Capacity with Resistance to Higher Global Amyloid Load and White Matter Hyperintensity Burden in Mild Stage Alzheimer's Disease.
Chang YT; Huang CW; Chen NC; Lin KJ; Huang SH; Chang YH; Hsu SW; Chang WN; Lui CC; Hsu CW; Chang CC
PLoS One; 2016; 11(2):e0149056. PubMed ID: 26872386
[TBL] [Abstract][Full Text] [Related]
2. Amyloid burden in the hippocampus and default mode network: relationships with gray matter volume and cognitive performance in mild stage Alzheimer disease.
Chang YT; Huang CW; Chang YH; Chen NC; Lin KJ; Yan TC; Chang WN; Chen SF; Lui CC; Lin PH; Chang CC
Medicine (Baltimore); 2015 Apr; 94(16):e763. PubMed ID: 25906109
[TBL] [Abstract][Full Text] [Related]
3. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
[TBL] [Abstract][Full Text] [Related]
4. Intra-individual correlations between quantitative THK-5351 PET and MRI-derived cortical volume in Alzheimer's disease differ according to disease severity and amyloid positivity.
Park JE; Yun J; Kim SJ; Shim WH; Oh JS; Oh M; Roh JH; Seo SW; Oh SJ; Kim JS
PLoS One; 2019; 14(12):e0226265. PubMed ID: 31834916
[TBL] [Abstract][Full Text] [Related]
5. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
[TBL] [Abstract][Full Text] [Related]
6. Amyloid PET imaging and dementias: potential applications in detecting and quantifying early white matter damage.
Pietroboni AM; Colombi A; Carandini T; Sacchi L; Fenoglio C; Marotta G; Arighi A; De Riz MA; Fumagalli GG; Castellani M; Bozzali M; Scarpini E; Galimberti D
Alzheimers Res Ther; 2022 Feb; 14(1):33. PubMed ID: 35151361
[TBL] [Abstract][Full Text] [Related]
7. Binding of
Hashimoto T; Yokota C; Koshino K; Temma T; Yamazaki M; Iguchi S; Shimomura R; Uehara T; Funatsu N; Hino T; Minematsu K; Iida H; Toyoda K
Ann Nucl Med; 2017 Apr; 31(3):227-234. PubMed ID: 28220365
[TBL] [Abstract][Full Text] [Related]
8. Reference region selection and the association between the rate of amyloid accumulation over time and the baseline amyloid burden.
Blautzik J; Brendel M; Sauerbeck J; Kotz S; Scheiwein F; Bartenstein P; Seibyl J; Rominger A;
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1364-1374. PubMed ID: 28326436
[TBL] [Abstract][Full Text] [Related]
9. Diffusion imaging in dementia with Lewy bodies: Associations with amyloid burden, atrophy, vascular factors and clinical features.
Donaghy PC; Firbank M; Petrides G; Lloyd J; Barnett N; Olsen K; Thomas AJ; O'Brien JT
Parkinsonism Relat Disord; 2020 Sep; 78():109-115. PubMed ID: 32814228
[TBL] [Abstract][Full Text] [Related]
10. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
Chételat G; Villemagne VL; Pike KE; Ellis KA; Bourgeat P; Jones G; O'Keefe GJ; Salvado O; Szoeke C; Martins RN; Ames D; Masters CL; Rowe CC;
Brain; 2011 Mar; 134(Pt 3):798-807. PubMed ID: 21310725
[TBL] [Abstract][Full Text] [Related]
11. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
[TBL] [Abstract][Full Text] [Related]
12. Effects of amyloid and small vessel disease on white matter network disruption.
Kim HJ; Im K; Kwon H; Lee JM; Ye BS; Kim YJ; Cho H; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Na DL; Seo SW
J Alzheimers Dis; 2015; 44(3):963-75. PubMed ID: 25374100
[TBL] [Abstract][Full Text] [Related]
13. White matter lesions characterise brain involvement in moderate to severe chronic obstructive pulmonary disease, but cerebral atrophy does not.
Spilling CA; Jones PW; Dodd JW; Barrick TR
BMC Pulm Med; 2017 Jun; 17(1):92. PubMed ID: 28629404
[TBL] [Abstract][Full Text] [Related]
14. Improved longitudinal [(18)F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction.
Brendel M; Högenauer M; Delker A; Sauerbeck J; Bartenstein P; Seibyl J; Rominger A;
Neuroimage; 2015 Mar; 108():450-9. PubMed ID: 25482269
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Free and Cued Selective Reminding Test Performance Using Volumetric and Amyloid-Based Biomarkers of Alzheimer's Disease.
Quenon L; Dricot L; Woodard JL; Hanseeuw B; Gilis N; Lhommel R; Ivanoiu A
J Int Neuropsychol Soc; 2016 Nov; 22(10):991-1004. PubMed ID: 27903329
[TBL] [Abstract][Full Text] [Related]
16. Exploration of neuroanatomical characteristics to differentiate prodromal Alzheimer's disease from cognitively unimpaired amyloid-positive individuals.
Kim HH; Kwon MJ; Jo S; Park JE; Kim JW; Kim JH; Kim SE; Kim KW; Han JW
Sci Rep; 2024 May; 14(1):10083. PubMed ID: 38698190
[TBL] [Abstract][Full Text] [Related]
17. Decreased Glucose Metabolism in Medial Prefrontal Areas is Associated with Nutritional Status in Patients with Prodromal and Early Alzheimer's Disease.
Sugimoto T; Nakamura A; Kato T; Iwata K; Saji N; Arahata Y; Hattori H; Bundo M; Ito K; Niida S; Sakurai T;
J Alzheimers Dis; 2017; 60(1):225-233. PubMed ID: 28826182
[TBL] [Abstract][Full Text] [Related]
18. BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain.
Sur C; Kost J; Scott D; Adamczuk K; Fox NC; Cummings JL; Tariot PN; Aisen PS; Vellas B; Voss T; Mahoney E; Mukai Y; Kennedy ME; Lines C; Michelson D; Egan MF
Brain; 2020 Dec; 143(12):3816-3826. PubMed ID: 33253354
[TBL] [Abstract][Full Text] [Related]
19. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
[TBL] [Abstract][Full Text] [Related]
20. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
